William H. Shrank
William H. Shrank publishes mostly in Economics and Econometrics, Family Practice and General Health Professions, on topics such as Medication Adherence and Compliance, Health Systems, Economic Evaluations, Quality of Life and Pharmaceutical Economics and Policy.
- World rank
- #21,373 of 7,710,434 ranked researchers
- Rank in United States
- #7,825 of 1,627,098
- Works
- 310
- Citations
- 20k
- Citations per work
- 65.4
What does William H. Shrank research?
William H. Shrank's work is mostly in Medicine (31%), Economics, Econometrics and Finance (26%), Health Professions (13%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences13644.0%
- Medicine9731.4%
- Health Professions3912.6%
- Everything else9430.3%
- Social Sciences8025.7%
- 1Economics and Econometrics26% of their works
- 2Family Practice15% of their works
- 3General Health Professions13% of their works
- 4Geriatrics and Gerontology7% of their works
- 5Endocrinology, Diabetes and Metabolism5% of their works
- 6Epidemiology4% of their works
Research topics
- Medication Adherence and Compliance
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Pharmaceutical Practices and Patient Outcomes
- Healthcare Policy and Management
- Chronic Disease Management Strategies
- Primary Care and Health Outcomes
- Pharmaceutical studies and practices
Which keywords describe William H. Shrank's research?
The keywords of their largest research topics: Chronic Disease Management, Medication Adherence, Patient Compliance, Treatment Adherence, Quality of Life, Primary Care, Cost-effectiveness Analysis and Health Utility Measures.
- Quality Improvement
- Off-Label Drug Use
- Multimorbidity
- Insurance Markets
- Polypharmacy
- Generic Drugs
- Health Utility Measures
- Primary Care
- Treatment Adherence
- Medication Adherence
- Chronic Disease Management
- Patient Compliance
- Quality of Life
- Cost-effectiveness Analysis
- Drug Development Costs
- Inappropriate Medication Use
- Health Care Spending
- Chronic Conditions
- Continuity of Care
- Pediatric Pharmacokinetics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Chronic Disease Management1632 topics
- Medication Adherence1632 topics
- Patient Compliance1361 topic
- Treatment Adherence1361 topic
- Quality of Life1242 topics
- Primary Care963 topics
- Cost-effectiveness Analysis951 topic
- Health Utility Measures951 topic
- Drug Development Costs791 topic
- Generic Drugs791 topic
- Inappropriate Medication Use661 topic
- Polypharmacy661 topic
- Health Care Spending401 topic
- Insurance Markets401 topic
- Chronic Conditions291 topic
- Multimorbidity291 topic
- Continuity of Care271 topic
- Off-Label Drug Use271 topic
- Pediatric Pharmacokinetics271 topic
- Quality Improvement271 topic
Where does William H. Shrank work?
William H. Shrank's main affiliation in the publication record is Brigham and Women's Hospital, United States.
How many publications and citations does William H. Shrank have?
OpenAlex counts 310 works and 20,265 citations for William H. Shrank, an h-index of 73, ranking #21,373 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about William H. Shrank. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.